Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
An EMT sorts through blood samples to test for COVID-19 antibodies at Abyssinian Baptist Church in Harlem, New York City on May 14. Photo: Angela Weiss/AFP via Getty Images
Antibody tests that identify those who have previously contracted the coronavirus should not be used to determine immunity, the American Medical Association cautioned in a Thursday report.
The big picture: Antibody tests help medical workers find out how widespread the coronavirus is in a given community, which New York state has pursued in recent weeks. These tests detect the antibodies the body produces when it fights off a coronavirus infection, but scientists don't know whether that translates into immunity, or how long such immunity might last.
What they're saying: The FDA "does not automatically independently verify performance" of antibody tests after granting them emergency authorization, the AMA writes — and tests that are not commercially marketed do not require FDA authorization.
- Antibody tests should not be used as justification for returning for work or discontinuing social distancing practices, the AMA says.
Where it stands: Roughly 12 commercial antibody tests have received emergency authorization by the FDA, while over 120 others are currently on the market, the AMA writes.
Go deeper: Coronavirus antibody tests see reliability and availability problems